Request for Reconsideration - PDCI Market Access

info@pdci.ca

Newsletter Sign-Up
Login to PDCI Services
Contact Us

Home
About
Services
News & Events
Publications

Request for Reconsideration

Home Request for Reconsideration

Request-for-Reconsideration-To-CADTH Download

July 2, 2020 / CADTH, What's New

Search

Categories

Categories

Recent Posts

*NEW* Report Release: “Issues and Opportunities to Modernize Private Drug Plan Sustainability in an Evolving Market”
Connect with PDCI Market Access at CDA Symposium 2024
PMPRB Releases Long Awaited Discussion Guide as Phase 2 of the New Guidelines Consultation Process
CADTH Update Introduces Streamlined Economic Reports and Launches BIA Template Consultation
New Issue of INSIGHTS Released

Newsletter Sign Up

TargetPharma is PDCI Market Access’ Free E-mail Newsletter

TargetPharma

TargetPharma is a free e-mail newsletter featuring the latest developments on policy, pricing and reimbursement in the pharmaceutical industry at the provincial and federal levels. Subscribe to stay informed on relevant activities within the PMPRB, the pCPA, CDA-AMC (formerly CADTH), Health Canada, and emerging issues and trends within Canada.

PDCI Market Access, a division of McKesson Canada Corporation
2300 Meadowvale Blvd.
Mississauga, ON L5N 5S1

E-mail: info@pdci.ca

If you are a Quebec resident and you have questions or comments about our efforts to protect your personal privacy, or if you require additional information about our privacy practices, please contact us at compliance@mckesson.ca. You may also write to our Privacy Officer at: McKesson Canada Corporation, Attn: Privacy Officer, 2300, Meadowvale Blvd., Mississauga, ON, L5N 5P9

© 2024 PDCI Market Access. All rights reserved.